Navigation Links
Essilor's First-Half 2008 Results
Date:8/27/2008

ffective

tax rate compared with a 32.0% rate for first-half 2007. The

improvement was driven by a lower average tax rate in Europe and

business growth in Asia, where the rate is below the Company average.

- The share of profit from associates-VisionWeb, Sperian

Protection and Transitions-which amounted to EUR14.7 million, versus

EUR15.3 million in first-half 2007. Earnings from Transitions declined

slightly to EUR9.6 million, from EUR10.1 million for the prior-year

period, because of a strongly negative currency effect and the

concentration of marketing costs in the first half related to the

launch of the sixth generation of variable-tint lenses in North

America.

Profit attributable to equity holders of the parent was 9.0% higher, at EUR198.3 million. Earnings per share rose by 8.1% to EUR0.96.

Inventories and work in progress

Inventories amounted to EUR400 million at June 30, 2008, compared with 394 million at December 31, 2007, a 1.5% increase. The like-for-like increase was 4.3%, below the rate of revenue growth.

Investments

Capital expenditure net of divestments totaled EUR95 million or 6.2% of consolidated revenue. Financial investments net of disposals amounted to EUR140.2 million. Of this amount, acquisitions accounted for EUR75.7 million, while buybacks of Essilor shares accounted for EUR64.5 million.
Cash Flow Statement

EUR millions

Net cash from operations 275 Capital expenditure 95

net of the proceeds

from asset sales

Proceeds from employee share 22 Change in WCR and 92

issue provisions

Net decrease in cash and 150 Dividends 129

cash equivalents

Effect of changes in 9 Financial investments 140

exchange rates and i
'/>"/>

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Biopure Announces 2008 Third Quarter Financial Results
2. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
3. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
4. Arpida Reports Interim Results for Six Months to 30 June 2008
5. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
6. Rosetta Genomics Reports Second Quarter 2008 Financial Results
7. VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
8. Arno Therapeutics Announces Second Quarter 2008 Financial Results
9. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
10. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
11. Yongye Biotechnology International Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)... CLAREMONT, Calif., Nov. 20 Keck ... second annual "Next Generation Bioscience Leaders...e Industry" (NGBL) forum will be held Jan. 19-23, ...cience companies. , , The forum is a partne...pment of business leaders in bioscience, and Smith...
(Date:11/20/2008)... SAN DIEGO, Nov. 20 PacificGMP, th...ent and manufacturing, has entered into a cGMP,co...aceuticals, a,biopharmaceutical company developin...greement, PacificGMP will manufacture and perform ...ody for a Phase I/II clinical trial. A,stability...
(Date:11/20/2008)..., Lumidigm, Inc. is proud...sor is one of 100 technologies and products recogn...s New™ for 2008. The Venus product is the fi...nsor available on the market. Designed for ease of...s exceptional real world biometric performance, li...
(Date:11/19/2008)... ISELIN, N.J., Nov. 19 S...d today that it has received FDA 510(k) clearance ...e intended to prevent post-operative adhesions in ...roximately two million nasal and sinus procedures ... Robert P. Hickey, SyntheMed,s President & C...
Breaking Biology Technology:KGI Announces Second Annual Executive Education Conference for Women in Life Sciences 2PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing 2 Lumidigm Biometric Sensor Included in Popular Science Best of What's New for 2008 : Venus Series Fingerprint Sensor Called a Breakthrough Product by the World's Largest Science and Technology Magazine 2 Lumidigm Biometric Sensor Included in Popular Science Best of What's New for 2008 : Venus Series Fingerprint Sensor Called a Breakthrough Product by the World's Largest Science and Technology Magazine 3SyntheMed Announces FDA Clearance of SinusShield(TM) 2
...Geneva, Wis . - Employers who are looking for heal...luence on healthcare premiums will have to wait a ...ial health information management organization. , ...are Information and Management Systems Society , ...proving interoperability between facilities remain...
... obligation does a trade owner have to purchase al...g to its trademark? If the trademark owner does no...he taking? Who has rights to domain names pertaini...posed by a reader regarding domains in his portfol... following principles can be used as guidelines wi...
... one week ago, 67 companies were nervously introdu...estors, business development executives, early ado...azing event. The on-stage demos were nearly flawle...he buzz in the pavilion was cacophonic. Heck, even...d upon us as the 67 companies delivered amazing pr...
...recent out-of-state challenges, including one from...consin Alumni Research Foundation (WARF) lack mer...rm in the United States. , ,Specifically, the proc...WARF, needs streamlining. Patent "trolls" need to ... Trademark Office (PTO), which has agreed to re-e...
Other Biology Technology:CEO of healthcare group still hopeful IT will save employers money 2CEO of healthcare group still hopeful IT will save employers money 3Is your business domain at risk? 2Is your business domain at risk? 3Is your business domain at risk? 4Basking (briefly) in the DEMOfall 2006 glow 2WARF challenges show need for patent reform 2WARF challenges show need for patent reform 3WARF challenges show need for patent reform 4
(Date:11/19/2008)... of marine invertebrates worms, sponges, jellyfis...t of no more than two cells: a photoreceptor cell ...spots, resemble the ,proto-eyes, suggested by Char...volution. They cannot form images but allow the an... is crucial for phototaxis the swimming towards l...
(Date:11/19/2008)... 24, 2008 -- From the collapse of star-forming clo...he combustion of gasoline in your car engine to th...ics of flight to the concentration of microscopic ...ating phenomena are forms of fluid flow. , The 6...y,s Division of Fluid Dynamics, which takes place ...
(Date:11/19/2008)...N -- (Nov. 19, 2008) -- Rice University scientists...born pollutant TCE have created a method that lets... a catalyst as individual chemical bonds are forme...e bonds between the atoms of our molecules," said ...e vibrations change frequency and intensity with t...
(Date:11/19/2008)...N, WI, NOVEMBER 17, 2008 -- One of the biggest thr...nic carbon (SOC) and soil organic matter (SOM) fro...these materials is essential as they do everything...ltering harmful chemical compounds to the preventi...es for crop residues are critical for maintaining ...
Breaking Biology News(10 mins):Uncovering secrets of life in the ocean 2The physics of star-forming clouds and the urban environment 2The physics of star-forming clouds and the urban environment 3The physics of star-forming clouds and the urban environment 4The physics of star-forming clouds and the urban environment 5The physics of star-forming clouds and the urban environment 6Researchers shed new light on catalyzed reactions 2Researchers shed new light on catalyzed reactions 3A model to measure soil health in the era of bioenergy 2New Yorks Excellus BlueCross BlueShield to Continue Generic Medication Promotion to Help Control Costs 24225 1New Yorks Excellus BlueCross BlueShield to Continue Generic Medication Promotion to Help Control Costs 24225 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients Accordin 2665 1Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients Accordin 2665 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients Accordin 2665 3Cepheid to Webcast Analyst Event 6656 1Cepheid to Webcast Analyst Event 6656 2American Biosurgical Adds David Brazeal CPA as Chief Financial Officer 24219 1American Biosurgical Adds David Brazeal CPA as Chief Financial Officer 24219 2
....S. Department of Energy,s Brookhaven National Lab...sed in medical imaging to track the distribution o...ated insect attack. The research provides new insi...pond to environmental stress, and shows that radio...nt biochemistry. , Done in collaboration with scie...
...the animal kingdom and beyond are characterized by...etches of DNA containing multiple genes that are c...e reason for this broad gene silencing is the vita...st unwanted recombinations of genetic material or ...nomic instability, particularly in the regions at ...
...ariants of particular genes patients with epilepsy...dose of drugs necessary to control their seizures,... University Institute for Genome Sciences & Po...ients often undergo a lengthy process of trial and...ropriate for them. , The researchers found that va...
...hocytic leukemia (B-CLL),is the most common leukem...ve accumulation of mature B lymphocytes in the blo...eved that in the early stages,of disease, B-CLL is...ed signals that trigger normal B cell death (apopt...versity School of Medicine now,demonstrate that hi...
Other Biology News:Poplar trees redirect resources in response to simulated attack 2Poplar trees redirect resources in response to simulated attack 3Enzyme shown to help protect genomic stability 2Gene variations explain drug dose required to control seizures 2Gene variations explain drug dose required to control seizures 3Gene variations explain drug dose required to control seizures 4
Rabbit polyclonal to Rad51 ( Abpromise for all tested applications). Antigen: Synthetic peptide: VEEESFGPQPISRLE conjugated to KLH, corresponding to N terminal amino acids 15-29 of Human Rad51
SYBR Green II RNA gel stain is a sensitive nucleic acid gel stain that has bright fluorescence when bound to RNA and low background in gels, making it ideal for use with either formaldehyde/agarose
SYBR Green II RNA gel stain is a sensitive nucleic acid gel stain that has bright fluorescence when bound to RNA and low background in gels, making it ideal for use with either formaldehyde/agarose
RORgamma (S-14)
Biology Products: